Véronique Riban

Véronique Riban has a diverse work experience in the field of pharmacology and preclinical research. Véronique is currently working as a Preclinical Project Manager at AELIS FARMA since November 2021. Prior to this, they worked at BIOCODEX INC for more than a decade from March 2010 to October 2021 in the role of Principal Research Scientist in Pharmacology. In this role, they managed both internal and external projects, supervised a team of technicians, and handled data reporting. Before that, they worked as a Safety Pharmacology Scientist at Servier from June 2009 to February 2010.

Their prior experience includes working as a Post-doctoral Researcher at The Ohio State University from May 2006 to June 2008, where they conducted experimental studies and designed and performed preclinical safety studies for a clinical trial on gene therapy for Parkinson's disease. Véronique also served as a Post-doctoral Researcher at UCLA, Los Angeles from 2002 to 2005, managing studies on stroke and Parkinson's disease and coordinating animal protocols submission and GLPs. Véronique started their career as a PhD student at INSERM U398 from 1999 to 2002.

Overall, Véronique Riban has a strong background in preclinical project management, pharmacology, and safety pharmacology, with significant experience in academic and industry settings.

Véronique Riban obtained their PhD in Neuropharmacology from Université Louis Pasteur (Strasbourg I) between 1998 and 2001. Additionally, they obtained a Certification for animal experiments, Level 1 from Louis Pasteur University in 2001. Véronique also holds a certification from ARC (Animal Research Committee) for laboratory animal users, obtained from UCLA. Finally, Véronique Riban has a Clinical Research Associate Certification (CRA) from ADDS, although the specific date of obtaining this certification is not provided.